Home  >  Products  >  BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) Blocking Peptide (the C terminal of BSCL2)(100ug)
BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) Blocking Peptide (the C terminal of BSCL2)(100ug)

BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) Blocking Peptide (the C terminal of BSCL2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BSCL2 Antibody(ARP50102_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP50102
Size: 100ug
Weight: 51kDa
Gene: 26580
Format: Lyophilized powder
Target: This gene encodes protein seipin, which is located in the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: GNG3LG; HMN5; MGC4694; SPG17
See Full Product Listings >